rs387906632
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_032638.5(GATA2):c.1009C>T(p.Arg337*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_032638.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATA2 | NM_032638.5 | c.1009C>T | p.Arg337* | stop_gained | Exon 4 of 6 | ENST00000341105.7 | NP_116027.2 | |
GATA2 | NM_001145661.2 | c.1009C>T | p.Arg337* | stop_gained | Exon 5 of 7 | NP_001139133.1 | ||
GATA2 | NM_001145662.1 | c.1009C>T | p.Arg337* | stop_gained | Exon 4 of 6 | NP_001139134.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATA2 | ENST00000341105.7 | c.1009C>T | p.Arg337* | stop_gained | Exon 4 of 6 | 1 | NM_032638.5 | ENSP00000345681.2 | ||
GATA2 | ENST00000487848.6 | c.1009C>T | p.Arg337* | stop_gained | Exon 5 of 7 | 1 | ENSP00000417074.1 | |||
GATA2 | ENST00000430265.6 | c.1009C>T | p.Arg337* | stop_gained | Exon 4 of 6 | 1 | ENSP00000400259.2 | |||
GATA2 | ENST00000696466.1 | c.1291C>T | p.Arg431* | stop_gained | Exon 6 of 8 | ENSP00000512647.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Monocytopenia with susceptibility to infections Pathogenic:1
- -
GATA2-related disorder Pathogenic:1
The GATA2 c.1009C>T variant is predicted to result in premature protein termination (p.Arg337*). This variant has been reported to be causative for GATA2-related disorders including MonoMAC, and primary lymphedema and predisposition to acute myeloid leukemia (Ostergaard et al. 2011. PubMed ID: 21892158; Hsu et al. 2013. PubMed ID: 23502222). This variant is not present in a large population database and has been interpreted as pathogenic in the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/29719/). Nonsense variants in GATA2 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Deafness-lymphedema-leukemia syndrome;C3280030:Monocytopenia with susceptibility to infections Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg337*) in the GATA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GATA2 are known to be pathogenic (PMID: 21670465, 23223431). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of GATA2 deficiency (PMID: 21892158, 23502222, 27894982). ClinVar contains an entry for this variant (Variation ID: 29719). For these reasons, this variant has been classified as Pathogenic. -
Deafness-lymphedema-leukemia syndrome Pathogenic:1
- -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23502222, 33684095, 21892158, 32770553, 34529785, 30538114, 27894982, 35753512) -
Deafness-lymphedema-leukemia syndrome;CN300066:GATA2 deficiency with susceptibility to MDS/AML Pathogenic:1
PVS1, PS4, PM2 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at